Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

DexCom, Inc. - Common Stock (NQ:DXCM)

83.56 -1.90 (-2.22%)
Streaming Delayed Price Updated: 11:09 AM EDT, Jul 11, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about DexCom, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
27 28 Next >
DEXCOM INC (NASDAQ:DXCM) - A Strong Technical Setup in the Medical Device Sector
DEXCOM INC (NASDAQ:DXCM) shows a strong technical setup with positive trends, consolidation, and institutional interest, making it a breakout candidate for traders. 
Via Chartmill
What Does the Market Think About DexCom?
Via Benzinga
2 Stocks to Buy on the Dip and Hold for 10 Years
Via The Motley Fool
3 Cash-Heavy Stocks Worth Your Attention
In a world where many businesses have shaky balance sheets, some have ignored the crowd and exercised prudence. These cash-heavy companies shine bright for their financial discipline, resilience, and... 
Via StockStory
DEXCOM INC (NASDAQ:DXCM) – A Strong Growth Stock with Technical Breakout Potential
DEXCOM INC (NASDAQ:DXCM) shows strong growth fundamentals and a promising technical setup, making it a stock to watch for breakout potential in the medical device sector. 
Via Chartmill
Price Over Earnings Overview: DexCom
Via Benzinga
Forecasting The Future: 7 Analyst Projections For DexCom
Via Benzinga
Why Diabetes Titans Dexcom, Tandem, Insulet Just Hit The Skids
A proposal would cut Medicare reimbursements for some medical devices using a competitive bidding process. 
Via Investor's Business Daily
What's going on in today's session: S&P500 gap up and gap down stocks
Let's have a look at the S&P500 gap up and gap down stocks in today's session. 
Via Chartmill
These S&P500 stocks are moving in today's pre-market session
Let's have a look at what is happening on the US markets before the opening bell on Tuesday. Below you can find the top S&P500 gainers and losers in today's pre-market session. 
Via Chartmill
2 S&P 500 Stocks Worth Investigating and 1 to Ignore
The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all large-cap stocks are created equal - some... 
Via StockStory
Topics Stocks
Abbott, Dexcom Draw Retail Buzz As RFK Jr. Urges Americans To Embrace Health Wearables
Retail sentiment surged on Stocktwits, with message volume jumping 1,600% for Abbott and 750% for Dexcom. 
Via Stocktwits
Uncover the latest developments among S&P500 stocks in today's session.
Let's have a look at what is happening on the US markets one hour before the close of the markets on Tuesday. Below you can find the top S&P500 gainers and losers in today's session. 
Via Chartmill
Entegris, Herc, Enovis, Commercial Vehicle Group, and DexCom Shares Skyrocket, What You Need To Know
A number of stocks jumped in the afternoon session after the major indices rebounded (Nasdaq +1.4%, S&P 500 +1.0%) on hopes the reported ceasefire between Israel and Iran will hold. This de-escalation... 
Via StockStory
Topics Economy Government Stocks
Top S&P500 movers in Tuesday's session
Curious about the S&P500 stocks that are in motion on Tuesday? Join us as we explore the top movers within the S&P500 index during today's session. 
Via Chartmill
Q1 Rundown: DexCom (NASDAQ:DXCM) Vs Other Patient Monitoring Stocks
Looking back on patient monitoring stocks’ Q1 earnings, we examine this quarter’s best and worst performers, including DexCom (NASDAQ:DXCM) and its peers. 
Via StockStory
Topics Artificial Intelligence
Expert Outlook: DexCom Through The Eyes Of 8 Analysts
Via Benzinga
1 Cash-Producing Stock on Our Buy List and 2 to Be Wary Of
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak... 
Via StockStory
DEXCOM INC (NASDAQ:DXCM) – A Strong Growth Stock with a Bullish Technical Setup
DEXCOM INC (NASDAQ:DXCM) shows strong growth fundamentals and a bullish technical setup, making it a stock worth watching for investors seeking growth opportunities. 
Via Chartmill
DEXCOM INC (NASDAQ:DXCM) - A Technical Breakout Candidate Worth Watching
DEXCOM INC (NASDAQ:DXCM) shows strong technicals and a high-quality setup, making it a potential breakout candidate. The stock's consolidation and bullish signals suggest a possible upward move. 
Via Chartmill
Goldman Sachs Bullish On Dexcom And Insulet As Diabetes Tech Surges
Goldman Sachs forecasts strong growth for diabetes tech, backing Dexcom and Insulet while rating Tandem and Beta Bionics as Neutral. 
Via Benzinga
2 Profitable Stocks on Our Watchlist and 1 to Turn Down
While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my... 
Via StockStory
Topics Supply Chain
Wednesday's session: top gainers and losers in the S&P500 index
Get insights into the S&P500 index performance on Wednesday. Explore the top gainers and losers within the S&P500 index in today's session. 
Via Chartmill
Stay informed with the top movers within the S&P500 index on Wednesday.
Curious about the S&P500 stocks that are in motion on Wednesday? Join us as we explore the top movers within the S&P500 index during today's session. 
Via Chartmill
Prediction: These 2 Stocks Will Beat the Market in the Next Decade
Via The Motley Fool
Topics Government
2 Momentum Stocks with Impressive Fundamentals and 1 to Avoid
Great things are happening to the stocks in this article. They’re all outperforming the market over the last month because of positive catalysts such as a new product line, constructive news flow, or... 
Via StockStory
3 Big Reasons to Love DexCom (DXCM)
Over the past six months, DexCom has been a great trade. While the S&P 500 was flat, the stock price has climbed by 15.6% to $87 per share. This was partly thanks to its solid quarterly results, and... 
Via StockStory
Topics Government Stocks
The End Of The Diabetes Industry? This Small Cap Could Upend The Business Models of Pharma Giants
is it the end of the diabetes industry? Here's a small cap that could upend the business models of pharma giants... 
Via Benzinga
DXCM Q1 Earnings Call: Coverage Expansion and Product Pipeline Shape 2025 Outlook
Medical device company DexCom (NASDAQ:DXCM) beat Wall Street’s revenue expectations in Q1 CY2025, with sales up 12.5% year on year to $1.04 billion. The company expects the full year’s revenue to be... 
Via StockStory
Topics Economy
DXC Tech Stock Slides On Sour Guidance, But Retail's Happy As Q4 Results Top Estimates
The company's bookings grew more than 20% for the second straight quarter, and the book-to-bill ratio exceeded one. 
Via Stocktwits
Topics Earnings
< Previous 1 2 3 4 5 6 7 8 9
...
27 28 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.